参考文献/References:
［1］ GOEDERT M,SPILLANTINI M G.A century of Alzheimer′s disease［J］.Science,2006,314(5800):777-781.
［2］ JACK C R J R,BENNETT D A,BLENNOW K,et al.NIA-AA research framework:toward a biological definition of Alzheimer′s disease［J］.Alzheimers Dement,2018,14(4):535-562.
［3］ 洪萍，王培昌，刘辰庚，等.阿尔茨海默病患者生物标志物的研究进展［J］.临床检验杂志，2014，32（7）：522-524.
［4］ HENRIKSEN K,O′BRYANT S E,HAMPEL H,et al.The future of blood-based biomarkers for Alzheimer′s disease［J］.Alzhemers Dement,2014,10(1):115-131.
［5］ 杨丽立，王维志.神经变性疾病脑脊液生物学标志物研究进展［J］.中国现代神经疾病杂志［J］.2013，13（2）：102-109.
［6］ FU Y,ZHAO D,YANG L,et al.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer′s disease［J］.J Mol Neurosci,2014,54(4):739-747.
［7］ VANDERMEEREN M,MERKEN M,VANMECHELEN E,et al.Detection of Tau proteins in normal and Alzheimer′s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay［J］.J Neurochem,1993,61(5):1828-1834.
［8］ ANDREASEN N,SJGREN M,BLENNOW K.CSF markers for Alzheimer′s disease:total Tau,phospho-Tau and Aβ42［J］.World J Biol Psychiatry,2003,4(4):147-155.
［9］ WU X L,PIA-CRESPO J,ZHANG Y W,et al.Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of Alzheimer′s disease［J］.Chin Med J (Engl),2017,130(24):2978-2990.
［10］ KOHNKEN R,BUERGER K,ZINKOWSKI R,et al.Detection of Tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer′s disease patients［J］.Neurosci Lett,2000,287(3):187-190.
［11］ TAKAHASHI R H,NAGAO T,GOURAS G K.Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer′s disease［J］.Pathol Int,2017,67(4):185-193.
［12］ WARAGAI M,SEKIYAMA K,SEKIGAWA A,et al.α-synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson′s disease［J］.Int J Mol Sci,2010,11(11):4257-4266.
［13］ FARAH R,HARATY H,SALAME Z,et al.Salivary biomarkers for the diagnosis and monitoring of neurological diseases［J］.Biomed J,2018,41(2):63-87.
［14］ SHI Y,HOLTZMAN D M.Interplay between innate immunity and Alzheimer disease:APOE and TREM2 in the spotlight［J］.Nat Rev Immunol,2018,18(12):759-777.
［15］ HU W T,HOLTZMAN D M,FAGAN A M,et al.Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease［J］.Neurology,2012,79(9):897-905.
［16］ JACK C R J R,KNOPMAN D S,CHTELAT G,et al.Suspected non-Alzheimer disease pathophysiology:concept and controversy［J］.Nat Rev Neurol,2016,12(2):117-124.
［17］ ROBINSON T O,SCHLUNS K S.The potential and promise of IL-15 in immuno-oncogenic therapies［J］.Immunol Lett,2017,190:159-168.
［18］ HALL J R,WIECHMANN A R,JOHNSON L A,et al.Biomarkers of vascular risk,systemic inflammation,and microvascular pathology and neuropsychiatric symptoms in Alzheimer′s disease［J］.J Alzheimers Dis,2013,35(2):363-371.
［19］ GOMEZ-NICOLA D,VALLE-ARGOS B,NIETO-SAMPEDRO M.Blockade of IL-15 activity inhibits microglial activation through the NF-κB,p38,and ERK1/2 pathways,reducing cytokine and chemokine release［J］.Glia,2010,58(3):264-276.
［20］ 方伟，张晓晨，刘遵建.神经丝蛋白AD7c-NTP在阿尔茨海默病临床诊断中的应用［J］.国际检验医学杂志，2012，33（22）：2712-2713.
［21］ DE LA MONTE S M,VOLICER L,HAUSER S L,et al.Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer′s disease［J］.Ann Neurol,1992,32(6):733-742.
［22］ GOODMAN I,GOLDEN G,FLITMAN S,et al.A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimer′s disease［J］.J Am Med Dir Assoc,2007,8(1):21-30.
［23］ JIN H,WANG R,LIU Z,et al.Some methodological characteristics of Alzheimer-associated urine neuronal thread protein detected by enzyme-linked immunosorbent assay［J］.J Alzheimers Dis,2018,63(1):255-262.
［24］ LEVY S,MCCONVILE M,LAZARO G A,et al.Competitive ELISA studies of neural thread protein in urine in Alzheimer′s disease［J］.Clin Lab Anal,2007,21(1):24-33.
［25］ GUPTA P,BHATTACHARJEE S,SHARMA A R,et al.miRNAs in Alzheimer disease:a therapeutic perspective［J］.Curr Alzheimer Res,2017,14(11):1198-1206.
［26］ SATOH J.Molecular network of microRNA targets in Alzheimer′s disease brains［J］.Exp Neurol,2012,235(2):436-446.
［27］ TAB L,YU JT,LIU QY,et al.Circulating miR-125b as a biomarker of Alzheimer′s disease［J］.J Neurol Sci,2014,336(1/2):52-56.
［28］ 段冉冉，李燕飞，贾延劼.与阿尔茨海默病发病机制相关的microRNA的研究进展［J］.中国神经精神疾病杂志，2013，39（9）：569-573.
［29］ BRYS M,PIRRAGLIA E,RICH K,et al.Predictional study of GSF biomarkers in mild cognitive impairement［J］.Neurobiol Aging,2009,30(5):682-690.
［30］ LISTA S,FALTRACO F,HAMPEL H.Biological and methodical challenges of blood-based proteomics in the field of neurological research［J］.Prog Neurobiol,2013,101(1):18-34.
［31］ BUERGER K,ERNST A,EWERS M,et al.Blood-based microcirculation markers in Alzheimer′s disease-diagnostic value of midregional proatrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio［J］.Biol Psychiatry,2009,65(11):979-984.
［32］ HENRIKSEN K,BYRJALSEN I,CHRISTIANSEN C,et al.Relationship between serum levels of Tau fragments and clinical progression of Alzheimer′s disease［J］.J Alzheimer′s Dis,2015,43(4):1331-1341.
［33］ ZHU T B,ZHANG Z,LUO P,et al.Lipid metabolism in Alzheimer′s disease［J］.Brain Res Bull,2018,144:68-74.
［34］ HAN X,ROZEN S,BOYLE S H,et al.Metabolomics in early Alzheimer′s disease:identification of altered plasma sphingolipidome using shotgun lipidomics［J］.PLoS One,2011,6(7):621-643.
相似文献/References:
[1]陈翀,李晓红,涂悦,等.糖原合成酶激酶3对大鼠创伤性脑损伤后认知功能的影响[J].新乡医学院学报,,():000.
[2]陈翀,李晓红,涂悦,等.糖原合成酶激酶3对大鼠创伤性脑损伤后认知功能的影响[J].新乡医学院学报,,():000.
[3]赵长安,王建伟,魏健,等.铝在阿尔茨海默病发生中的作用[J].新乡医学院学报,2003,20(02):106.
[4]赵长安,王建伟,魏 健,等.铝在阿尔茨海默病发生中的作用[J].新乡医学院学报,2003,20(02):106.
[5]赵长安,魏健,王建伟。.阿尔茨海默病中tau蛋白和铝的变化及二者的关系[J].新乡医学院学报,2003,20(03):189.
[6]赵长安,魏 健,王建伟.阿尔茨海默病中tau蛋白和铝的变化及二者的关系[J].新乡医学院学报,2003,20(03):189.
[7]赵长安,王悦芬,郭丽,等.糖化牛血清白蛋白及其抗体的制备[J].新乡医学院学报,2007,24(05):462.
[8]张强,李宛青,刘华.氦氖激光对阿尔茨海默病模型大鼠脑组织MAP2和bcl-2表达的影响 [J].新乡医学院学报,2007,24(01):015.
[9]段敬利,穆俊林,潘伟盟.阿尔茨海默病患者盐酸美金刚治疗前后认知功能变化与事件相关电位 Ｐ３００关系分析[J].新乡医学院学报,2015,32(12):1122.
[10]张 琦,姜 泓,冯慧玲.新生儿脑损伤生物标志物研究进展[J].新乡医学院学报,2019,36(10):990.[doi:10.7683/xxyxyxb.2019.10.021]